There was a peculiar smell in the pharmaceutical factory.

Shen Qi didn't mind, and even felt very kind, because this was his own pharmaceutical factory.

Lao Shen successfully completed the industrial transformation, from the owner of the auto parts factory to the owner of the pharmaceutical factory.

Whether he can take care of Obeqi Pharmaceutical can be taken care of, Lao Shen actually has no bottom in his heart, so he asked his son to come back for inspection.

The original boss has already flashed, and the one who accompanied the Shen family father and son to inspect the pharmaceutical factory was the manager, surnamed Qiu, a little old man in his fifties.

OBEQI Pharmaceutical has injection production line, tablet and capsule production line, and solid preparation production line.

This pharmaceutical factory is a small and medium-sized pharmaceutical factory in terms of sales scale, but its production scale is by no means small.

With this kind of production scale, the annual sales volume is only more than 10 million RMB, which cannot be continued, so the original boss who vomited blood at a loss quit, and he resolutely transferred Obeqi Pharmaceutical to the Shen consortium with an unfathomable background.

The workshop is still in operation and has not been shut down due to the change of owner.

In fact, many grassroots employees don't know that they have changed bosses.

Manager Qiu has already found out that the only son of the new boss Shen Zhishan is the well-known scientist Shen Qi.

Judging from the books, Shen Qi has nothing to do with Obeqi Pharmaceutical, but soon after Manager Qiu contacted Shen Qi, he found that Boss Xiao Shen had more power to speak.

Boss Xiao Shen is knowledgeable and seems to know a lot about the pharmaceutical industry. Manager Qiu said as he walked: "Boss Shen, Boss Shen, you have also seen that the production scale of our factory is not small, it is a regular factory, and it has fallen to this point today, and it can be summed up in only four words, and the management is not good." ”

"Definitely. Shen Qi said that he likes Manager Qiu's pragmatic style: "There is a problem with the marketing strategy of the factory, before this, I have never heard of any product of the factory, this is because the product structure of the factory is messy, everything is done, there is no focus." ”

Manager Qiu smiled bitterly: "Boss Xiao Shen, you got to the point." ”

Originally only made chemical drugs, their first product was an injection drug for cardiovascular diseases, which was generic, but the imitation effect was good.

For the second product, Obeqi Pharmaceutical imitated Liyuexi and got the production approval.

Later, OBEQI Pharmaceutical began to make Chinese patent medicines. Up to now, the product structure of OBIQI Pharmaceutical Co., Ltd. includes 33 varieties of drugs, half of which are chemical drugs and Chinese patent medicines, and half of them are made of cardiovascular system, respiratory system, antibiotics, heat clearing and detoxification, kidney tonic and aphrodisiac, anesthesia and sedation.

That's the problem, the product structure is chaotic, and there are no star products.

When it comes to Sino-American SmithKline, ordinary people know their cold medicine Contec.

When it comes to correction medicine, everyone will think of their stomach disease drug Starshu.

And Obeqi Pharmaceutical, the devil knows what medicine they do.

Ordinary people buy mobile phones to recognize the brand, buy cars to recognize the brand, buy drugs and even more recognize the brand, who dares to buy a mess of miscellaneous brands such as medicine?

"I just want to ask, where is the chief engineer of Liyuexi's development team?" Shen Qi had limited time, and he asked questions to focus on.

Before coming to the pharmaceutical factory, Shen Qi had already figured out the development history, product structure and marketing status of Obeqi Pharmaceutical.

Obeqi Pharmaceutical is making generic drugs, and as soon as other people's patents expire, they will soon be able to launch generic drugs.

Among so many generic products of Obiqi Pharmaceutical, Shen Qi believes that the most technical is Liyuexi/Midazolam.

Midazolam was first developed and marketed by the international pharmaceutical giant Roche Pharmaceutical, and at present, only three pharmaceutical companies in the country have imitated it and obtained production approval.

Liyuexi is an anesthetic, which is strictly controlled by the state, and this kind of central nervous system drug may become an angel or a devil because of its special chemical and physiological properties.

Obtaining approval in such a strictly controlled narcotic drug market segment, Obeqi Pharmaceutical originally hoped to create a powerful product, but because of their poor marketing management, they broke down.

Liyuexi's sales in China are basically monopolized by a pharmaceutical company in East China, and Obeqi Pharmaceutical and Renfu Pharmaceutical are in an extremely passive competitive position.

Of course, if Obeqi Pharmaceutical goes smoothly and creates one or even several star products and monopoly products, there will be nothing to do with the Shen consortium.

Shen Qi still wanted to meet the chief engineer of Li Yuexi's development team, and he felt that this engineer was a usable talent.

"Boss Xiao Shen laughed, our factory, how can there be any chief engineer......" Manager Qiu himself was embarrassed, he laughed embarrassedly: "We are producing generic drugs, there used to be a master craftsman, he led a few college students, and he made Li Yuexi out." ”

"What about the old master?" asked Shen Qi.

"The old master has retired. Manager Qiu said.

"Oh, that's right. Shen Qi didn't ask, so he continued to visit the factory.

At the end of the day's investigation, Shen Qi and his father returned home.

Shen Qi pointed out the problem with a sharp point: "Dad, our factory must be mentally prepared to lose money every year for at least three years." ”

Lao Shen: "I am mentally prepared, and I have asked a professional team to evaluate it." ”

"In order to stop the loss and reduce the amount of losses, I propose to stop the production of 30 kinds of medicines, and in the next three years, we will only produce Yuexi, Qiangyang Kidney Protection Pill, and Liuwei Dihuang Pill...... Hey, I think it's funny when I talk about it, anesthesia and sedation, aphrodisiac nourishment, chemical medicine, Chinese patent medicine, mixed together, this product pedigree is too confusing. Shen Qi touched his forehead, it was so messy.

"As far as the strong yang kidney protection pill and Liuwei Dihuang pill we produce, the effect is still good, I have tried it. Liyuexi is an anesthetic, and it seems that I used Liyuexi when I had surgery last time, and it was Liyuexi produced by someone else. "Lao Shen Gan loves his line, he quickly completed the role change and tried the medicine himself.

Shen Qi said: "Among the existing products, the three drugs I just mentioned, we are competitive, especially Liyuexi, we are one of the top three in the country. If you can do marketing well, you might be able to break even. If we want to make a profit, we have to make original drugs, of course, making original drugs is very expensive and takes a long time, but I have a solution. ”

Shen Qi's idea is that we will not make uncompetitive drugs and stop production. Otherwise, the more you produce, the more you lose.

Within three years, the hope of the whole village is that the three drugs of Liyuexi, Qiangyang Kidney Protection Pill and Liuwei Dihuang Pill will be good in the marketing of these three drugs, and it will be difficult to turn losses into profits, and strive to break even.

Three or several years later, our factory's original drug will be on the market, and we may be profitable.

Can an original drug save a factory?

Yes, one is to look at the efficacy, and the other is to look at luck.

To get Lipitor, Pfizer spent more than $80 billion to buy Warner Lambert, the company that developed Lipitor.

Of course, Pfizer didn't trade at a loss, and they sold Lipitor for more than $10 billion a year.

Then the most critical problem is that OBEQI Pharmaceutical does not even have a R&D department, and the imitation business is completed by the process technology department. Where does the original drug come from?

In fact, Shen Qi has the prototype of an original drug in his hand, that is, C01C.

Samples of C01C have been synthesized in the Yanda laboratory, and the paper will be published soon, and the patent will be in place.

What follows is a series of tests, the most troublesome of which is clinical trials.

These tests are completed by qualified institutions, and OBEQI Pharmaceuticals has a dedicated follow-up team to follow up on the progress of the tests.

After finding out, Shen Qi returned to Yanda and personally sorted out the laboratory synthesis data of C01C.

There is a problem here, Shen Qi made a sample of C01C in the laboratory of Yanda University, and the patent ownership of C01C belongs to the state.

When you sell a patent in a university, you sell the right to develop a patent. Shen Qi sold a few patents before, and he and his team took a part of the transfer fee, and handed over the rest to Yanda.

In this event, Shen Qi will play two roles, one is a professor of Yanda University, the inventor of the patent, and the other is the son of the boss of Obeqi Pharmaceutical.

This matter still has to be communicated well in advance, otherwise some people may gossip, okay Shen Qi, use national resources to expand the family business.

Shen Qi found Director Qi of the Yanda Technology Transfer Center and handed over the information of C01C to Director Qi: "Old Qi, this information is about a new compound, and I still have to trouble you to apply for a patent and transfer a patent." ”

"Old Shen, don't be so polite, this is my duty. "Director Qi is very familiar with Shen Qi, and he has helped Shen Qi get several patents before.

"In some institutions and companies, there is a fixed-point investment system, that is, Party A wants to do a project, not the conventional process of shopping around, but designating a supplier to bid. In the field of patent transfer, is there also a fixed-point assignment system?" asked Shen Qi.

Lao Qi is a smart person, he quickly understood Shen Qi's voiceover, he patted the information bag in his hand, and asked, "Who do you want to transfer this patent to?"

Shen Qi got straight to the point: "Nangang Obeqi Pharmaceutical Company." ”

"What is your relationship with this company?" Lao Qi asked very directly, it was precisely because of the good relationship that he asked bluntly.

Shen Qi said calmly: "I have nothing to do with this company legally. ”

Lao Qi breathed a sigh of relief: "That's no problem, one is willing to buy, the other is willing to sell, and it can be transferred at a fixed point." ”

Shen Qi said again: "The boss of this company is my father. ”

"Does this matter?" Lao Qi Xian's surprise, he immediately understood: "If you don't have the equity of that company, don't participate in the management of the company, and don't have any positions in the company, then legally speaking, you really have nothing to do with that company." It's not that troublesome, just make it clear, according to the market, the patent should be sold as much as you want, and it's fine. ”

"Thank you, Lao Qi, I owe you a favor. Shen Qi made a gesture, this gesture represents, go, I invite you out for a big drink.

"Business. "Lao Qi is really business-oriented, but he uses flexible handling skills in the process of business.

......

(The third watch wrote more than 7,000 words, but I really can't write 8,000 words...... My eyes are blind, my hands are broken, and this chapter was uploaded by my mother for me...... Ask for a commuter pass...... ）